Search Results Search Sort by RelevanceMost Recent Case and Commentary Jan 2005 An HIV Diagnosis, Option Assessment Abraham P. Schwab, MA Virtual Mentor. 2005;7(1):48-52. doi: 10.1001/virtualmentor.2005.7.1.ccas9a-0501. Case and Commentary Jan 2005 An HIV Diagnosis, Option Comparison Abraham P. Schwab, MA Virtual Mentor. 2005;7(1):48-52. doi: 10.1001/virtualmentor.2005.7.1.ccas9b-0501. Case and Commentary Jan 2005 An HIV Diagnosis, Additional Information Abraham P. Schwab, MA Virtual Mentor. 2005;7(1):48-52. doi: 10.1001/virtualmentor.2005.7.1.ccas9c-0501. Case and Commentary Mar 2009 Is There a Duty to Inform Patients of Phase I Trials? Commentary 1 Courtenay R. Bruce, JD and Anne Lederman Flamm, JD Physicians must ask themselves ethical questions before recommending participation in phase I trials to patients. Virtual Mentor. 2009;11(3):207-211. doi: 10.1001/virtualmentor.2009.11.3.ccas2-0903. Case and Commentary Mar 2009 Is There a Duty to Inform Patients of Phase I Trials? Commentary 2 Thomas W. LeBlanc, MD, MA and Philip M. Rosoff, MD, MA Physicians must ask themselves ethical questions before recommending participation in phase I trials to patients. Virtual Mentor. 2009;11(3):211-214. doi: 10.1001/virtualmentor.2009.11.3.ccas2-0903. Case and Commentary May 2006 Physician Values and Clinical Decision Making, Commentary 1 Jack Drescher, MD Physicians are encouraged to resist the temptation to allow their personal lifestyle beliefs to affect the treatment that they give to patients. Virtual Mentor. 2006;8(5):303-306. doi: 10.1001/virtualmentor.2006.8.5.ccas2-0605. Case and Commentary May 2006 Physician Values and Clinical Decision Making, Commentary 2 Andrew Fergusson, MB, MRCGP Physicians are encouraged to resist the temptation to allow their personal lifestyle beliefs to affect the treatment that they give to patients. Virtual Mentor. 2006;8(5):306-308. doi: 10.1001/virtualmentor.2006.8.5.ccas2-0605. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 1 Charles Weijer, MD, PhD Physicians are obligated to inform patients involved in a clinical trial that there is a chance of receiving a placebo, which can result in a deterioration of a medical condition. Virtual Mentor. 2004;6(11):482-484. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Current page 3 Page 4 Next page Next › Last page Last »
Case and Commentary Jan 2005 An HIV Diagnosis, Option Assessment Abraham P. Schwab, MA Virtual Mentor. 2005;7(1):48-52. doi: 10.1001/virtualmentor.2005.7.1.ccas9a-0501.
Case and Commentary Jan 2005 An HIV Diagnosis, Option Comparison Abraham P. Schwab, MA Virtual Mentor. 2005;7(1):48-52. doi: 10.1001/virtualmentor.2005.7.1.ccas9b-0501.
Case and Commentary Jan 2005 An HIV Diagnosis, Additional Information Abraham P. Schwab, MA Virtual Mentor. 2005;7(1):48-52. doi: 10.1001/virtualmentor.2005.7.1.ccas9c-0501.
Case and Commentary Mar 2009 Is There a Duty to Inform Patients of Phase I Trials? Commentary 1 Courtenay R. Bruce, JD and Anne Lederman Flamm, JD Physicians must ask themselves ethical questions before recommending participation in phase I trials to patients. Virtual Mentor. 2009;11(3):207-211. doi: 10.1001/virtualmentor.2009.11.3.ccas2-0903.
Case and Commentary Mar 2009 Is There a Duty to Inform Patients of Phase I Trials? Commentary 2 Thomas W. LeBlanc, MD, MA and Philip M. Rosoff, MD, MA Physicians must ask themselves ethical questions before recommending participation in phase I trials to patients. Virtual Mentor. 2009;11(3):211-214. doi: 10.1001/virtualmentor.2009.11.3.ccas2-0903.
Case and Commentary May 2006 Physician Values and Clinical Decision Making, Commentary 1 Jack Drescher, MD Physicians are encouraged to resist the temptation to allow their personal lifestyle beliefs to affect the treatment that they give to patients. Virtual Mentor. 2006;8(5):303-306. doi: 10.1001/virtualmentor.2006.8.5.ccas2-0605.
Case and Commentary May 2006 Physician Values and Clinical Decision Making, Commentary 2 Andrew Fergusson, MB, MRCGP Physicians are encouraged to resist the temptation to allow their personal lifestyle beliefs to affect the treatment that they give to patients. Virtual Mentor. 2006;8(5):306-308. doi: 10.1001/virtualmentor.2006.8.5.ccas2-0605.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 1 Charles Weijer, MD, PhD Physicians are obligated to inform patients involved in a clinical trial that there is a chance of receiving a placebo, which can result in a deterioration of a medical condition. Virtual Mentor. 2004;6(11):482-484. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411.